GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

and HBV DNA after 24 weeks' treatment to below the lower limit of detection in people with chronic hepatitis B, raising hopes that it could offer permanent cure, allowing safe termination of ...

A population-based, retrospective cohort study examining the risk of HCC and mortality in 1096 treated and 1096 matched untreated HCV/HBV dually infected patients. CI, confidence interval ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Analysts at William Blair have suggested that the market for an HBV cure could be around the same size as for hepatitis C virus, which peaked at around $10 billion a year, but was a short-lived ...

p < 0.001), in the absence of cirrhosis (HBV-40%, HCV-0%; p < 0.001), and a decreased eligibility for curative treatment (HBV-14%, HCV-34%; p < 0.05). Conversely, patients with HCV were more ...

TAIPEI (Taiwan News) – Kaohsiung Medical University President Yu Ming-lung (余明隆) and South Korea's University of Ulsan College of Medicine Dean Lim Young-suk (林永錫) have found early antiviral treatment ...

Vaccines can help prevent hepatitis A and B. People who are unvaccinated and who develop hepatitis B "can live a long life with effective treatment and support from … clinicians," Kuncio said.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

Aligos Therapeutics Inc. has disclosed programmed cell death 1 (PDCD1; PD-1; CD279) and/or PD-1 ligand 1 (PD-L1; CD274) and/or PD-1/PD-L1 interaction inhibitors reported to be useful for the treatment ...